Fyavolv is an oral tablet that is taken once daily.

• Daily Dosing: Take one tablet every day at approximately the same time each day. This helps maintain a consistent level of hormones in your body.
• With or Without Food: You can take Fyavolv with or without food.
• Consistent Use: It’s important to take Fyavolv continuously, as prescribed, without missing doses. Missing doses can lead to irregular bleeding or spotting.
• Blister Packs: Fyavolv often comes in convenient blister packs designed to help you remember to take a pill each day. Follow the instructions on the package.
• Regular Check-ups: Your doctor will schedule regular check-ups (typically every 3 to 6 months) to determine if you still need HRT and to monitor your response and any potential side effects. The goal is to use the lowest effective dose for the shortest duration necessary to achieve your treatment goals.

Do not stop taking Fyavolv or change your dose without first talking to your doctor.

During menopause, a woman’s body produces less estrogen, leading to the symptoms and health risks associated with this transition. Fyavolv works by replacing these declining hormone levels.

• Ethinyl Estradiol (Estrogen component): This hormone helps to replenish the body’s estrogen supply. By increasing estrogen levels, it effectively reduces the frequency and severity of hot flashes and night sweats. It also helps to prevent bone loss, which is a major concern after menopause, thereby reducing the risk of osteoporosis.
• Norethindrone Acetate (Progestin component): When estrogen is taken alone, it can cause the lining of the uterus (endometrium) to thicken, which increases the risk of endometrial cancer. The progestin in Fyavolv counteracts this effect. It helps to keep the uterine lining thin, significantly reducing the risk of uterine cancer in women who still have their uterus.

Together, these two hormones work to alleviate menopausal symptoms and provide bone protection, while managing the risk to the uterus.

• Replenishes declining estrogen levels during menopause.
• Estrogen reduces hot flashes, night sweats, and prevents bone loss.
• Progestin prevents the uterine lining from thickening.
• Progestin lowers the risk of uterine cancer caused by estrogen alone.
• Combines to alleviate symptoms and protect bone health safely.

Like all medications, Fyavolv can cause side effects. It’s important to discuss these with your doctor. Common side effects usually include:

• Breast pain or tenderness.
• Headache.
• Nausea, vomiting, abdominal pain, or bloating.
• Swelling (edema) of ankles, hands, or feet.
• Irregular vaginal bleeding or spotting: This is especially common during the first few months of starting treatment and often resolves. Report any unusual or persistent bleeding to your doctor.
• Mood changes or depression.
• Weight changes.
• Hair loss.

More serious, but less common, side effects include:

• Blood clots: Increased risk of blood clots in the legs (DVT), lungs (PE), or leading to stroke or heart attack. This risk is generally low, especially for women under 60.
• Gallbladder disease.
• Liver problems.
• High blood pressure.
• Breast cancer: A small increased risk with long-term use of combined HRT.
• Stroke or Heart Attack: Increased risk, particularly in older women or those with pre-existing risk factors.

Your doctor will discuss these risks with you and monitor for any signs of serious side effects.

Before starting or continuing Fyavolv, several important warnings and precautions must be considered:

• Medical History: Provide your complete medical history, especially if you have a history of blood clots, stroke, heart attack, certain cancers (breast, uterine), liver disease, abnormal vaginal bleeding, or undiagnosed vaginal bleeding.
• Not for Pregnancy: Do not use Fyavolv if you are pregnant or trying to become pregnant. HRT is not a form of birth control.
• Blood Clots: Discuss your risk factors for blood clots (e.g., smoking, obesity, family history, prolonged immobility, certain medical conditions).
• Breast Cancer: Discuss your personal and family history of breast cancer. Regular breast exams and mammograms are important.
• Endometrial Cancer: While the progestin in Fyavolv reduces this risk, any unusual vaginal bleeding after menopause should be reported to your doctor immediately.
• Heart Disease/Stroke: HRT should not be used to prevent heart disease or stroke.
• Gallbladder Disease: Increased risk of gallbladder problems.
• Liver Problems: Use with caution if you have liver disease.
• Diabetes: Monitor blood sugar levels closely, as HRT can affect them.
• Smoking: Strongly advised not to smoke, as it significantly increases serious risks.
• Surgery/Immobility: If you are having surgery or will be on prolonged bed rest, your doctor might advise you to stop Fyavolv temporarily to reduce the risk of blood clots.

Fyavolv can interact with several other medications, which can affect how it works or increase the risk of side effects. It’s crucial to inform your doctor and pharmacist about all prescription drugs, over-the-counter medications, herbal products, and supplements you are using. Some important interactions include:

• Aromatase Inhibitors: Medicines like anastrozole, exemestane, or letrozole (used for breast cancer) should not be taken with Fyavolv, as Fyavolv contains estrogen which can interfere with their action.
• Certain Antibiotics: Some antibiotics (e.g., erythromycin, clarithromycin) may affect how Fyavolv is processed in the body.
• Certain Antifungals: Some oral antifungals (e.g., ketoconazole, itraconazole) can increase Fyavolv levels.
• Certain Anti-seizure Medicines: Drugs like phenobarbital, carbamazepine, or phenytoin can decrease Fyavolv’s effectiveness.
• Thyroid Hormones: If you are on thyroid replacement therapy, your thyroid hormone dose might need adjustment as HRT can affect thyroid function tests.
• Grapefruit Juice: Drinking grapefruit juice can increase the levels of estrogen in your body, potentially leading to more side effects. Avoid grapefruit products while taking Fyavolv.
• Smoking: Smoking significantly increases the risk of serious cardiovascular side effects like blood clots, heart attack, and stroke, especially in women over 35.

Fyavolv is available in different strengths, typically 0.5 mg norethindrone acetate / 0.0025 mg ethinyl estradiol and 1 mg norethindrone acetate / 0.005 mg ethinyl estradiol.

• Standard Dosage: The usual starting and maintenance dose is one tablet taken orally once daily.
• Lowest Effective Dose: Your doctor will aim to prescribe the lowest effective dose for the shortest possible duration that provides relief from your symptoms and meets your treatment goals, while minimizing risks.
• Continuous Regimen: Fyavolv is designed for continuous daily dosing.
• Monitoring: Regular medical evaluations (e.g., every 3 to 6 months) are crucial to reassess your need for HRT, check for side effects, and adjust the dosage if necessary. Your doctor will weigh the benefits against the risks periodically.

Always take Fyavolv exactly as prescribed by your healthcare provider. Do not adjust your dose or stop taking it without medical advice.

Fyavolv is a prescription-only medication (POM). It is not available over-the-counter. Due to its hormonal nature, its potential benefits, and its associated risks (such as an increased risk of blood clots, stroke, heart attack, and certain cancers), Fyavolv must be prescribed by a licensed medical doctor. A thorough medical evaluation, including a review of your personal and family medical history, is essential before starting HRT. Your doctor will assess your menopausal symptoms, bone health, and individual risk factors to determine if Fyavolv is an appropriate and safe treatment option for you. Ongoing medical supervision and regular follow-up appointments are crucial while on Fyavolv. You can obtain Fyavolv from pharmacies in Pakistan, but only with a valid prescription.

• Fyavolv is a prescription-only medication (POM).
• Not available over-the-counter.
• Requires a valid prescription from a licensed doctor.
• Medical evaluation and risk assessment are essential before prescribing.
• Ongoing medical supervision and regular follow-up are necessary.

What is Fyavolv used for? Relief of menopausal symptoms (hot flashes, night sweats, vaginal dryness) and prevention of osteoporosis

2. What are the active ingredients? Estradiol (estrogen) and norethindrone acetate (progestin)

3. What drug class does it belong to? Hormone replacement therapy (HRT)

4. Is Fyavolv a controlled substance? No

5. Is Fyavolv available in generic form? Yes—estradiol/norethindrone combinations exist

6. How is Fyavolv administered? Orally, as tablets

7. What strengths are available? Estradiol 0.5 mg + norethindrone acetate 0.1 mg per tablet

8. What is the usual adult dosage? One tablet daily

9. Can it be used in children? No—intended only for postmenopausal women

10. What are common side effects? Breast tenderness, headache, nausea, bloating, mood changes

11. Can it cause serious reactions? Yes—increased risk of blood clots, stroke, heart attack, breast cancer, endometrial cancer

12. Is Fyavolv safe during pregnancy? No—contraindicated in pregnancy

13. Is a prescription required? Yes

14. Is Fyavolv available in Pakistan? Not widely; other HRT combinations may be available

15. How should it be taken? Swallow tablet whole, at the same time each day

16. What precautions should be taken during use? Use lowest effective dose for shortest duration; regular checkups recommended

17. What are contraindications? History of breast cancer, endometrial cancer, thromboembolic disease, liver disease, undiagnosed vaginal bleeding

18. What monitoring is needed during use? Blood pressure, breast exams, pelvic exams, lipid profile, liver function

19. Can Fyavolv be combined with other medications? Caution with anticoagulants, thyroid medications, and CYP3A4 inhibitors/inducers

20. What are similar drugs? Activella, Mimvey, Prempro (other estrogen + progestin HRTs)